During this fireside chat we welcome Aytu BioPharma CEO Josh Disbrow. Aytu is a pharmaceutical company commercializing a portfolio of commercial prescription therapeutics and consumer health products.

This Fireside Chat was recorded during the Lytham Partners Fall 2023 Investor Conference.